Abstract
Metabolic syndrome contributes to pathogenesis of Type-2 diabetes and CAD. Insulin Resistance is the key factor of metabolic syndrome implicated in development of Non Alcoholic Fatty Liver Disease (NAFLD). In present study we have investigated the prevalence of NAFLD in metabolic syndrome and contribution of metabolic risk factors in causation of NAFLD in non-diabetic North Indian male population. The study was conducted on 495 non-diabetic, nonalcoholic subjects (age 30–65 years). Metabolic Syndrome was assessed by using ATP III and ADA (2005) criteria. Anthropometric factors-Waist circumference and blood pressure were measured. Fasting serum samples were analyzed for Glucose, Triglycerides, Cholesterol and its fractions, Insulin, Alanine transaminase, Aspartate transaminase, Gamma glutamyl transferase and free fatty acids. Insulin resistance was estimated by Homeostasis Model and Insulin sensitivity by QUICKI Index. Liver ultrasonographic scanning was used for assessing fatty liver. The prevalence of metabolic syndrome and NAFLD was 24% and 14.8% respectively in non-alcoholic population and 27% of metabolic syndrome had NAFLD which was associated with hyperinsulinemia, insulin resistance, insulin insensitivity along with elevated levels of waist circumference, blood pressure, triglyceride, FFA and decreased HDL-Cholesterol. The prevalence of NAFLD increased with insulin resistance and clustering of metabolic risk factors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow up study. Hepatology 1995; 22: 1714–1719.
Neuschwander Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202–1219.
Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northen Italy. Ann Intern Med 2000; 132: 112–117.
Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649–1657.
Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854–858.
Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929–1934.
Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate AM, Rasciti L, et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004; 53: 1020–1023.
Diehl AM. Fatty liver, hypertension and the metabolic syndrome. Gut 2004; 53: 923–924.
Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl 2003; 134: 18–27.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Alexander CM, Landsman PB, Teutch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants aged 50 years and older. Diabetes 2003; 52: 1210–1214.
Wilson WF, Grundy SM. The metabolic syndrome: Practical guide to origins and treatment:I. Circulation 2003; 108: 1422–1425.
Wilson WF, Grundy SM. The metabolic syndrome: Practical guide to origins and treatment:II. Circulation 2003; 108: 1537–1540.
Cortez Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999; 18: 353–358.
Angelico F, De Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588–594.
Marchesini G, Bugianesi E, Forlani G, Cerelli F, Lenzi M, Manini R, Rizzetto M, Melchionda N. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003; 37: 917–923.
Alberti KGMM, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005;366:1059–1062.
Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentration. Diabetologia 1985; 28: 412–419.
Levy JC, Matthews DR, Herman MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191–2192.
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.
Saverymuttu SH, Joseph AEA, Amxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13–15.
Goya S, Wannamenthee, Shaper AG, Lennon L, Whincup PH. Hepatic Enzymes, the metabolic syndrome and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913–2918.
Aithal GP. Liver enzymes and Aristotle’s Art. JR Coll Physicians Edinb 2008; 38: 40–41.
Mathur SK, Chandra P, Mishra S, Ajmera P, Sharma P. Type-2 diabetes related intermediate phenotypic traits in North Indian diabetics. Ind J Clin Biochem 2007; 22(2): 70–73.
Sharma P, Mishra S, Ajmera P, Mathur S. Oxidative stress in metabolic syndrome. Ind J Clin Biochem 2005; 20(1): 145–149.
Sharma P, Mishra S. Metabolic Syndrome: Early identification prevents type II diabetes and cardiovascular disease. Ind J Clin Biochem 2007; 22(1): 1–3.
Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201–229.
Unger RH. Minireview: weapons of lean body body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinol 2003; 144: 59–65.
Joseph AE, Saverymuttu SH, al-Sam S. Cook MG, Maswell JD. Comparison of liver histology with ultra sonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26–31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mishra, S., Yadav, D., Gupta, M. et al. Hyperinsulinemia predisposes to NAFLD. Indian J Clin Biochem 23, 130–135 (2008). https://doi.org/10.1007/s12291-008-0030-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-008-0030-6